CLINICAL_TRIALS
trial_result
· 2017-01-31
Clinical Trial Update: Mediastinal Grey Zone Lymphoma From the LYSA
Summary
The LYSA-sponsored clinical trial NCT03037177 focusing on mediastinal grey zone lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: Mediastinal Grey Zone Lymphoma | Status: COMPLETED